| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-2952(03)00413-1 |
| P698 | PubMed publication ID | 12963477 |
| P2093 | author name string | Gary D Stoner | |
| Michael V Darby | |||
| Thomas Walle | |||
| Alexander C Whitley | |||
| P2860 | cites work | Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA | Q24564700 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 | Q28141205 | ||
| Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid | Q28274294 | ||
| Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries | Q32128813 | ||
| Biosynthesis and subcellular distribution of hydrolyzable tannins | Q34291897 | ||
| Etiology and chemoprevention of esophageal squamous cell carcinoma | Q34430903 | ||
| Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells | Q35003095 | ||
| Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence | Q35413790 | ||
| Molecular mechanisms of quinone cytotoxicity | Q37367251 | ||
| Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid | Q37404720 | ||
| Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium | Q38457410 | ||
| Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells | Q41032453 | ||
| Use of methanolysis for the determination of total ellagic and gallic acid contents of wood and food products | Q43582193 | ||
| Free radical studies of ellagic acid, a natural phenolic antioxidant | Q43922978 | ||
| Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection | Q44023965 | ||
| Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells | Q44445733 | ||
| Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3'-di-O-methylellagic acid in mice | Q50202753 | ||
| Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. | Q53414795 | ||
| The crystal and molecular structure of ellagic acid dihydrate: a dietary anti-cancer agent | Q53495208 | ||
| Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. | Q53537918 | ||
| Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells | Q61696721 | ||
| Disposition of the plant phenol ellagic acid in the mouse following oral administration by gavage | Q68460165 | ||
| Ellagic acid metabolism and binding to DNA in organ explant cultures of the rat | Q69204525 | ||
| Irreversible binding and metabolism of propranolol by human liver microsomes--relationship to polymorphic oxidation | Q70347967 | ||
| Interaction between ellagic acid and calf thymus DNA studied with flow linear dichroism UV-VIS spectroscopy | Q73175406 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polyphenol | Q290439 |
| P304 | page(s) | 907-915 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid--extensive binding to protein and DNA. | |
| P478 | volume | 66 |
| Q39450289 | A comprehensive review of agrimoniin |
| Q36692058 | Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice. |
| Q34569704 | Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells |
| Q38168765 | Cellular polarity in aging: role of redox regulation and nutrition. |
| Q46385007 | Chemical composition of rosehips from different Rosa species: an alternative source of antioxidants for the food industry. |
| Q47211511 | Chemical composition, antioxidant and antibacterial activities of two Spondias species from Northeastern Brazil |
| Q41854058 | Cytochemistry and C-values: the less-well-known world of nuclear DNA amounts |
| Q37214184 | Differential effects of several phytochemicals and their derivatives on murine keratinocytes in vitro and in vivo: implications for skin cancer prevention |
| Q42152168 | Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson's Disease |
| Q41949030 | Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson's disease |
| Q40161300 | Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells |
| Q46970952 | Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats |
| Q46816015 | Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression |
| Q37536730 | Ellagitannin-rich cloudberry inhibits hepatocyte growth factor induced cell migration and phosphatidylinositol 3-kinase/AKT activation in colon carcinoma cells and tumors in Min mice |
| Q35966929 | Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts |
| Q42688385 | Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles |
| Q55069618 | JAK2 and AMP-kinase inhibition in vitro by food extracts, fractions and purified phytochemicals. |
| Q35636550 | Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries |
| Q48451393 | Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). |
| Q34977600 | Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention |
| Q91839518 | Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation |
| Q34576670 | Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review |
| Q37908854 | Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals. |
| Q43110172 | Pomegranate Intake Protects Against Genomic Instability Induced by Medical X-rays In Vivo in Mice. |
| Q38381476 | Potential Benefits of Edible Berries in the Management of Aerodigestive and Gastrointestinal Tract Cancers: Preclinical and Clinical Evidence. |
| Q46927914 | Protective effect of ellagic acid against TCDD-induced renal oxidative stress: modulation of CYP1A1 activity and antioxidant defense mechanisms |
| Q33802503 | Research progress on the anticarcinogenic actions and mechanisms of ellagic acid |
| Q53575666 | Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. |
| Q38803522 | Scope of Hydrolysable Tannins as Possible Antimicrobial Agent |
| Q58691080 | Synthesis, Characterization, and Evaluation of Radical Scavenging Ability of Ellagic Acid-Loaded Nanogels |
| Q37479432 | Tannins: current knowledge of food sources, intake, bioavailability and biological effects. |
| Q40902235 | The antioxidant effects of pomegranate extract on local and remote organs in a mesenteric ischemia and reperfusion model. |
| Q38108784 | The pharmacological use of ellagic acid-rich pomegranate fruit |
| Q33838470 | Therapeutic Applications of Rose Hips from Different Rosa Species. |
| Q40072086 | Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. |
Search more.